Volume 5 Supplement 8
Application of hydrocyclones for continuous cultivation of SP-2/0 cells in perfusion bioreactors: Effect of hydrocyclone operating pressure
© Elsayed and Wagner; licensee BioMed Central Ltd. 2011
Published: 22 November 2011
Hydrocyclones (HCs) have been recently extensively evaluated for their application in the separation of mammalian cells in perfusion bioreactors. The high centrifugal force derived within hydrocyclones is the key mechanism for cell separation inside such small-sized simple devices. This is usually accompanied by a very short residence time of the cells inside the separating equipment, usually not more than 0.2 s. Moreover, they have other specific characteristics, which highly recommend their application for the production of pharmaceutical products in perfusion cultivation bioreactors. They are characterized by their high performance, robustness, lack of movable parts, ease of in situ sterilization and suitability for cleaning-in-place processes.
Materials and methods
The hydrocyclone HC 2520, specially designed for cell cultivation, was used for separation of the recombinant mouse lymphoid cell line SP-2/0. It has a 25-mm underflow and 20-mm overflow orifice. A pulsation-free pumphead (Watson Marlow 505L) was fitted to a WM 505DU pump and the perfusion was performed intermittently. Cell were cultured on serum-free ZKT-1 medium supplemented with 5% foetal bovine serum.
Effect of hydrocyclone operating pressure on cell growth and cell viability
Effect of hydrocyclone operating pressure on separation efficiency and separated cell quality
Hydrocyclone can be successfully used for cell separation in continuous mammalian perfusion bioreactors.
Cells adapt themselves to the shear forces inside the HC without being adversely affected by the pressure.
Higher separation efficiencies up to 96% can be achieved depending on the operating HC pressure.
HCs separate preferably more living cells in the underflow, thus more dead cells are leaving the system, which will finally lead to the improvement of system viability and product quality.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.